Milton Generic Profile
Key Indicators
- Authorised Capital ₹ 0.50 M
as on 17-11-2024
- Paid Up Capital ₹ 0.10 M
as on 17-11-2024
- Company Age 15 Year, 9 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 6.59 Cr
as on 17-11-2024
- Satisfied Charges ₹ 2.50 M
as on 17-11-2024
- Revenue -7.92%
(FY 2023)
- Profit -14.78%
(FY 2023)
- Ebitda -81.10%
(FY 2023)
- Net Worth 9.97%
(FY 2023)
- Total Assets 29.48%
(FY 2023)
About Milton Generic
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.50 M and a paid-up capital of Rs 0.10 M.
The company currently has active open charges totaling ₹6.59 Cr. The company has closed loans amounting to ₹2.50 M, as per Ministry of Corporate Affairs (MCA) records.
Anil Jain, Akshay Jain, and Arun Vaishnav serve as directors at the Company.
- CIN/LLPIN
U85100MH2009PTC191828
- Company No.
191828
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
20 Apr 2009
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Company Details
- Location
Mumbai, Maharashtra, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Milton Generic?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Akshay Jain  | Director | 18-Jan-2018 | Current |
| Anil Jain | Director | 20-Apr-2009 | Current |
| Arun Vaishnav | Director | 20-Apr-2009 | Current |
Financial Performance of Milton Generic.
Milton Generic Private Limited, for the financial year ended 2023, experienced Minor drop in revenue, with a 7.92% decrease. The company also saw a substantial fall in profitability, with a 14.78% decrease in profit. The company's net worth moved up by a moderate rise of 9.97%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Milton Generic?
Unlock access to Milton Generic's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Hdfc Bank Limited Creation Date: 13 Oct 2011 | ₹6.59 Cr | Open |
Ing Vysya Bank Limited Creation Date: 27 Jan 2011 | ₹2.50 M | Satisfied |
How Many Employees Work at Milton Generic?
Unlock and access historical data on people associated with Milton Generic, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Milton Generic, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Milton Generic's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
